Global Gene Therapy Market Report, Size, Share, Opportunities, And Trends By Therapy Type (Ex Vivo, In Vivo, In Situ), By Vector Type (Viral, Non-Viral), By Technique Type (Gene Augmentation, Gene Inhibition, Killing Of Specific Cells), By Disease Type (Cancer, Heart Disease, Diabetes, HIV, Others), And By Geography - Forecasts From 2025 To 2030

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Sources

2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Product Pipeline

5. GLOBAL GENE THERAPY MARKET, BY THERAPY TYPE

5.1. Introduction

5.2. Ex Vivo

5.3. In Vivo

5.4. In Situ

6. GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE

6.1. Introduction

6.2. Viral

6.3. Non-Viral

7. GLOBAL GENE THERAPY MARKET, BY TECHNIQUE TYPE

7.1. Introduction

7.2. Gene Augmentation

7.3. Gene Inhibition

7.4. Specific Cell Kill

8. GLOBAL GENE THERAPY MARKET, BY DISEASE TYPE

8.1. Introduction

8.2. Cancer

8.3. Heart Disease

8.4. Diabetes

8.5. HIV 

8.6. Others

9. GLOBAL GENE THERAPY MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Shanghai Sunway Biotech Co. Ltd

11.2. Pfizer In

11.3. Astellas Gene Therapies, Inc.

11.4. Novartis Gene Therapies

11.5. MeiraGTx

11.6. San Rocco Therapeutics

11.7. American Gene Technologies

11.8. Lysogene

11.9. AVROBIO Inc

11.10. Adverum Biotechnologies Inc

11.11. Spark Therapeutics, Inc.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES